A series of studies have shown that GFAP predicts conversion to AD in MCI individuals [93] and that tau accumulation occurs only in cognitively normal Aβ-positive individuals with increased levels of GFAP [94]. The gene discussed is GFAP; the disease is Alzheimer disease.